Aurobindo Pharma Ltd gets Form 483 from USFDA with 1 observation

The United States Food and Drug Administration (US FDA) inspected Unit VI - B, a Formulation manufacturing facility of Aurobindo Pharma Ltd, situated at Chitkul Village, Patancheru Mandal, Sangareddy District, Telangana, from September 22 to September 29, 2023.

At the end of the inspection, a 'Form 483' was issued with 1 observation which is procedural in nature. We will respond to the US FDA within the stipulated timelines and work closely with US FDA to close the observation at the earliest.

Shares of Aurobindo Pharma Limited was last trading in BSE at Rs. 914.20 as compared to the previous close of Rs. 874.00. The total number of shares traded during the day was 335955 in over 11159 trades.

The stock hit an intraday high of Rs. 930.00 and intraday low of 902.00. The net turnover during the day was Rs. 309101726.00.

Source : Equity Bulls

Keywords

AurobindoPharma INE406A01037 USFDA Inspection Form483